Cineline India Reports Strong Q1 FY27 Performance; Revenue Jumps 28% Amid Operational Gains
Cineline India Limited, identified as one of the fourth largest film exhibition players in India, has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported robust growth across key metrics, including a significant rise in revenue and profitability.
The Q1 FY27 results reflect strong operational momentum, supported by continued audience engagement and effective execution. Total Revenue stood at INR 6,002 lakh in the quarter, marking a 28% increase compared to Q1 FY26. Earnings before Interest, Depreciation, and Amortization (EBITDA) saw an exceptional increase of 106%, reaching INR 605 lakh.
The company's financial highlights for Q1 FY27 are detailed below:
| Particulars (INR Lakhs) | Q1 FY27 | Q1 FY26 | Year-on-Year Change |
|---|---|---|---|
| Total Revenue | 6,002 | 4,673 | +28% |
| EBITDA | 605 | 294 | +106% |
| EBITDA Margin % | 10.1% | 6.3% | +380 bps |
| PAT # | 34 | -22 | NA |
| Cash PAT # | 477 | 355 | +34% |
Key Operational Metrics and Business Strength
The operational matrix for the quarter shows healthy growth in consumer engagement. Admissions reached 18.0 lakh, a 29% rise from Q1 FY26. Net Box Office Collections grew by 32%, reaching INR 3,615 lakh, while Net F&B Collections increased by 29%, amounting to INR 1,856 lakh.Operational details for the company include:
| Particulars | Q1 FY27 | Q1 FY26 | Year-on-Year Change |
|---|---|---|---|
| ATP (Average Ticket Price) | INR 236 | INR 232 | +2% |
| SPH (Spend Per Head) | INR 108 | INR 108 | +0% |
| ATP + SPH | INR 345 | INR 340 | +1% |
Cineline reported operational metrics across 22 cinemas and 85 screens, serving customers in 15 cities. The company's portfolio includes over 21,100 seats.
Management Commentary and Growth Strategy
Ashish Kanakia, CEO of Cineline India Limited, commented on the performance, attributing the strong operational and financial results to the sustained momentum created by various releases, including Dhurandar: The Revenge, Raja Shivaji, and others. He noted that revenue at INR 6,002 lakh (Pre Ind-AS) and a 106% increase in EBITDA reflected healthy consumer demand.The company reaffirmed its strategy to expand, expecting to add between 20 and 25 screens during FY27, with the launch of three new screens in Gurgaon scheduled for Q2 FY27. Cineline is actively pursuing expansion into South India to establish a foothold in this resilient market segment.
Cineline continues to drive growth through several strategic priorities:
- Expansion in Southern Region: The company aims to build a diversified national footprint by entering high-potential southern cities, leveraging the premium MovieMAX experience and localized content strategy.
- Compelling Cinema Queue: Cineline expects to sustain audience engagement with a diverse slate across Hindi, Hollywood, and regional releases.
- Asset-Light O&M Model: The company is accelerating growth by partnering with developers to launch multiplexes using an Operations & Management (O&M) model, thus limiting capital investment while improving return ratios.
Looking ahead, Cineline anticipates a diverse content pipeline, which includes Bollywood titles such as Ramayana: Part 1, King, Toxic, and Vann -Force of the Forest, alongside Hollywood releases like The Odyssey and Avengers: Doomsday. The company remains focused on enhancing the movie-going experience through premium formats, recliner auditoriums, and advanced projection technologies.
CINELINE Stock Price Movement
Shares of Cineline India Limited slipped by 5.78% on Monday, closing at ₹82.29 after a session marked by significant downward movement. The stock traded with a volume totaling 82,731 shares as it finished the day in the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.